Skip to main content

Medicare: Observations on Program Sustainability and Strategies to Control Spending on Any Proposed Drug Benefit

GAO-03-650T Published: Apr 09, 2003. Publicly Released: Apr 09, 2003.
Jump To:
Skip to Highlights

Highlights

The House Committee on Ways and Means is holding a hearing on modernizing Medicare and integrating prescription drugs into the program. There are growing concerns about gaps in the Medicare program, most notably the lack of outpatient prescription drug coverage, which may leave Medicare's most vulnerable beneficiaries with high out-of-pocket costs. At the same time, Medicare already faces a huge projected financial imbalance that has worsened significantly in the past year. This statement discusses the challenges of adding a drug benefit to Medicare in the context of the program's current and projected financial condition. It also examines program design issues to be considered with respect to administering any proposed drug benefit. Specifically, it discusses how private sector health plans have used entities called pharmacy benefit managers (PBM) to control drug benefit expenditures.

Full Report

Office of Public Affairs

Topics

Budget activitiesDrugsFuture budget projectionsHealth care cost controlHealth care programsHealth insuranceHealth insurance cost controlManaged health careMedicareTrust funds